CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to LRVIY

Study group - quadrivalent recombinant hemagglutinin influenza vaccine

Phase 3
Laboratorios Farmaceuticos Rovi, S.A./ADR (LRVIY)

Phase 3

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.